Bcl-2 expression in breast cancer is down-regulated by trans-arterial administration of chemotherapeutic agents

Oncology Reports

Volumn 8, Issue 5, 2001, Pages 1019-1022

  Sato, Tadamitsu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bcl 2 expression, immunohistochemistry; Breast cancer; Preoperative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; EPIRUBICIN; PACLITAXEL; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; DISEASE FREE SURVIVAL; DOWN REGULATION; DRUG EFFECT; DRUG RESISTANCE; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFUSIONS, INTRA-ARTERIAL; MIDDLE AGED; NEOPLASM INVASIVENESS; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0035458467     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.5.1019     Document Type: Article

References (2)

1. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
2. Reed JC: Mechanisms of apoptosis. Am J Pathol 157: 1415-1430, 2000.